@article{ref1,
title="Superior safety of reboxetine over amitryptiline in the elderly",
journal="European journal of medical research",
year="2002",
author="Agelink, Marcus W. and Ullrich, H. and Passenberg, P. and Sayar, K. and Brockmeyer, N. H.",
volume="7",
number="9",
pages="415-416",
abstract="Under antidepressive treatment with amitryptiline (100 mg/d) a 71-year old woman developed delirious symptoms, hyponatremia and a grand mal seizure followed by cardiovascular arrest. A few month later she ingested 48 mg reboxetine with suicidal intent. Overdosing of reboxetine, a selective noradrenaline re-uptake inhibitor, proceeded without complications.<p /><p>Language: en</p>",
language="en",
issn="0949-2321",
doi="",
url="http://dx.doi.org/"
}